相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study
F. Valenzuela et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
The Impact of Biologics and Tofacitinib on Cardiovascular Risk Factors and Outcomes in Patients with Rheumatic Disease: A Systematic Literature Review
Michael Nurmohamed et al.
DRUG SAFETY (2018)
Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1 beta in non-ST-elevation myocardial infarction
Ola Kleveland et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Linking energy sensing to suppression of JAK-STAT signalling: A potential route for repurposing AMPK activators?
Claire Speirs et al.
PHARMACOLOGICAL RESEARCH (2018)
Influence of Diabetes on Long-Term Coronary Artery Bypass Graft Patency
Sajjad Raza et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Impact of type 2 diabetes mellitus on the long-term mortality in patients who were treated by coronary artery bypass surgery A systematic review and meta-analysis
Pravesh K. Bundhun et al.
MEDICINE (2017)
Meprin Metalloproteases Generate Biologically Active Soluble Interleukin-6 Receptor to Induce Trans-Signaling
Philipp Arnold et al.
SCIENTIFIC REPORTS (2017)
The Soluble Interleukin 6 Receptor: Advanced Therapeutic Options in Inflammation
Stefan Rose-John
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
The JAK/STAT pathway in obesity and diabetes
Esteban N. Gurzov et al.
FEBS JOURNAL (2016)
Vein graft failure: from pathophysiology to clinical outcomes
Margreet R. de Vries et al.
NATURE REVIEWS CARDIOLOGY (2016)
Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2016)
Calpastatin Counteracts Pathological Angiogenesis by Inhibiting Suppressor of Cytokine Signaling 3 Degradation in Vascular Endothelial Cells
Takuro Miyazaki et al.
CIRCULATION RESEARCH (2015)
Interleukin-6: Biology, signaling and strategies of blockade
Fred Schaper et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
STAT3 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin
Xing-Hua Liao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Aberrant Phenotype in Human Endothelial Cells of Diabetic Origin: Implications for Saphenous Vein Graft Failure?
Anna C. Roberts et al.
JOURNAL OF DIABETES RESEARCH (2015)
Effects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Agata N. Burska et al.
PLOS ONE (2015)
Suppressor of Cytokine Signaling 1-Derived Peptide Inhibits Janus Kinase/Signal Transducers and Activators of Transcription Pathway and Improves Inflammation and Atherosclerosis in Diabetic Mice
Carlota Recio et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
IL-6 in diabetes and cardiovascular complications
Dan Qu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors
Johanna C. Bendell et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Circulating Inflammatory Markers and the Risk of Vascular Complications and Mortality in People With Type 2 Diabetes and Cardiovascular Disease or Risk Factors: The ADVANCE Study
Gordon Lowe et al.
DIABETES (2014)
Reconstruction of an active SOCS3-based E3 ubiquitin ligase complex in vitro: identification of the active components and JAK2 and gp130 as substrates
Nadia J. Kershaw et al.
GROWTH FACTORS (2014)
Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function
Kirsten Riches et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Suppressor of Cytokine Signaling 3 Is a Negative Regulator for Neointimal Hyperplasia of Vein Graft Stenosis
Shui Xiang et al.
JOURNAL OF VASCULAR RESEARCH (2014)
SOCS and diabetes-ups and downs of a turbulent relationship
Dariusz Suchy et al.
CELL BIOCHEMISTRY AND FUNCTION (2013)
Inhibitory effects of suppressor of cytokine signaling 3 on inflammatory cytokine expression and migration and proliferation of IL-6/IFN-γ-induced vascular smooth muscle cells
Shui Xiang et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2013)
Therapeutic modulators of STAT signalling for human diseases
Gabriella Miklossy et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition
Nadia J. Kershaw et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
MECHANISMS OF DIABETIC COMPLICATIONS
Josephine M. Forbes et al.
PHYSIOLOGICAL REVIEWS (2013)
Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation
Jan-Marcus Daniel et al.
BASIC RESEARCH IN CARDIOLOGY (2012)
Pathophysiology of saphenous vein graft failure: a brief overview of interventions
Nilima Shukla et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
Interleukin-6 signalling: More than Jaks and STATs
Rene Eulenfeld et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2012)
Suppression of Cytokine Signaling by SOCS3: Characterization of the Mode of Inhibition and the Basis of Its Specificity
Jeffrey J. Babon et al.
IMMUNITY (2012)
IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3
Ben A. Croker et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
Ronald F. van Vollenhoven et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Sustained Reduction of Vein Graft Neointima Formation by Ex Vivo TIMP-3 Gene Therapy
Sarah J. George et al.
CIRCULATION (2011)
Human Vascular Endothelial Cells: A Model System for Studying Vascular Inflammation in Diabetes and Atherosclerosis
Duygu Onat et al.
CURRENT DIABETES REPORTS (2011)
Suppressor of cytokine signaling-3 and intimal hyperplasia in porcine coronary arteries following coronary intervention
Gaurav K. Gupta et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2011)
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Simon A. Jones et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Comprehensive analysis of kinase inhibitor selectivity
Mindy I. Davis et al.
NATURE BIOTECHNOLOGY (2011)
The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling
Daniela Ungureanu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Integrins in Cell Migration
Anna Huttenlocher et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Endothelial Gene Expression in Regions of Defined Shear Exposure in the Porcine Iliac Arteries
Jeffrey A. LaMack et al.
ANNALS OF BIOMEDICAL ENGINEERING (2010)
Statins suppress interleukin-6-induced monocyte chemo-attractant protein-1 by inhibiting Janus kinase/signal transducers and activators of transcription pathways in human vascular endothelial cells
Michihisa Jougasaki et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein
R. S. Mughal et al.
DIABETOLOGIA (2010)
Suppressors of Cytokine Signaling Abrogate Diabetic Nephropathy
Guadalupe Ortiz-Munoz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Intensive glycemic control and cardiovascular disease: an update
Aparna Brown et al.
NATURE REVIEWS CARDIOLOGY (2010)
Inherent differences in morphology, proliferation, and migration in saphenous vein smooth muscle cells cultured from nondiabetic and Type 2 diabetic patients
Haifa A. Madi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Suppressors of Cytokine Signaling Modulate JAK/STAT-Mediated Cell Responses During Atherosclerosis
Guadalupe Ortiz-Munoz et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
CREB-Mediated IL-6 Expression Is Required for 15(S)-Hydroxyeicosatetraenoic Acid-Induced Vascular Smooth Muscle Cell Migration
Koteswara R. Chava et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT)
Aramesh Saremi et al.
ATHEROSCLEROSIS (2009)
Trends in All-Cause and Cardiovascular Disease Mortality Among Women and Men With and Without Diabetes Mellitus in the Framingham Heart Study, 1950 to 2005
Sarah Rosner Preis et al.
CIRCULATION (2009)
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials A Position Statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association
Jay S. Skyler et al.
CIRCULATION (2009)
5-Year Clinical Outcomes After Sirolimus-Eluting Stent Implantation Insights From a Patient-Level Pooled Analysis of 4 Randomized Trials Comparing Sirolimus-Eluting Stents With Bare-Metal Stents
Adriano Caixeta et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
William Duckworth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Late thrombosis of paclitaxel-eluting stents:: Long-term incidence, clinical consequences, and risk factors in a cohort of 604 patients
Xacobe Flores-Rios et al.
AMERICAN HEART JOURNAL (2008)
Níveis séricos de interleucina-6 (IL-6), interleucina-18 (IL-18) e proteína C reativa (PCR) na síndrome coronariana aguda sem supradesnivelamento do ST em pacientes com diabete tipo 2
José Roberto Matos Souza et al.
Arquivos Brasileiros de Cardiologia (2008)
Activated STAT3 is a mediator and biomarker of VEGF endothelial activation
Shao-Hua Chen et al.
CANCER BIOLOGY & THERAPY (2008)
The SOCS box domain of SOCS3: Structure and interaction with the elonginBC-cullin5 ubiquitin ligase
Jeffrey J. Babon et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
CRP, IL-6 and endothelin-1 levels in patients undergoing coronary artery bypass grafting. Do preoperative inflammatory parameters predict early graft occlusion and late cardiovascular events?
Anders Hedman et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Smooth muscle cells cultured from human saphenous vein exhibit increased proliferation, invasion, and mitogen-activated protein kinase activation in vitro compared with paired internal mammary artery cells
Neil A. Turner et al.
JOURNAL OF VASCULAR SURGERY (2007)
The final 10-year follow-up results from the BARI randomized trial
Maria Mori Brooks et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Exchange protein activated by cyclic AMP (Epac)-mediated induction of suppressor of cytokine signaling 3 (SOCS-3) in vascular endothelial cells
William A. Sands et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
The structure of SOCS3 reveals the basis of the extended SH2 domain function and identifies an unstructured insertion that regulates stability
JJ Babon et al.
MOLECULAR CELL (2006)
Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3
K Leslie et al.
CANCER RESEARCH (2006)
Secondary structure assignment of mouse SOCS3 by NMR defines the domain boundaries and identifies an unstructured insertion in the SH2 domain
JJ Babon et al.
FEBS JOURNAL (2005)
JANUS under stress - Role of JAK/STAT signaling pathway in vascular diseases
K Grote et al.
VASCULAR PHARMACOLOGY (2005)
Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis
D Jo et al.
NATURE MEDICINE (2005)
SLIM is a nuclear ubiquitin E3 ligase that negatively regulates STAT signaling
T Tanaka et al.
IMMUNITY (2005)
Effect of risk-adjusted morbidity after coronary diabetes on mortality and artery bypass surgery
C Kubal et al.
ANNALS OF THORACIC SURGERY (2005)
Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery - Results from a department of veterans affairs cooperative study
S Goldman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Molecular regulation of vascular smooth muscle cell differentiation in development and disease
GK Owens et al.
PHYSIOLOGICAL REVIEWS (2004)
Inflammation: the link between insulin resistance, obesity and diabetes
P Dandona et al.
TRENDS IN IMMUNOLOGY (2004)
Regulation of cytokine signaling by SOCS family molecules
M Fujimoto et al.
TRENDS IN IMMUNOLOGY (2003)
Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE)
V Matthews et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathways
CCL Wang et al.
DIABETES (2003)
Negative regulation of FAK signaling by SOCS proteins
E Liu et al.
EMBO JOURNAL (2003)
Tyrosine phosphorylation disrupts elongin interaction and accelerates SOCS3 degradation
S Haan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
High glucose accelerates MCP-1 production via p38 MAPK in vascular endothelial cells
H Takaishi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Inflammatory cytokines and the risk to develop type 2 diabetes -: Results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study
J Spranger et al.
DIABETES (2003)
The N-terminal truncated isoform of SOCS3 translated from an alternative initiation AUG codon under stress conditions is stable due to the lack of a major ubiquitination site, Lys-6
A Sasaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Influence of type 2 diabetes on functional and structural properties of coronary artery bypass conduits
R Lorusso et al.
DIABETES (2003)
Outcomes of repeat revascularization in diabetic patients with prior coronary surgery
JH Cole et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis
T Shouda et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Mapping of a region within the N terminus of Jak1 involved in cytokine receptor interaction
C Haan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Mortality and causes of death in the WHO multinational study of vascular disease in diabetes
NJ Morrish et al.
DIABETOLOGIA (2001)
Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion
B Vozarova et al.
OBESITY RESEARCH (2001)
Injury induces dedifferentiation of smooth muscle cells and increased matrix-degrading metalloproteinase activity in human saphenous vein
JL Johnson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130
SE Nicholson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors
T Hirano et al.
ONCOGENE (2000)
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men
PM Ridker et al.
CIRCULATION (2000)
Expression of intercellular adhesion molecules in human saphenous veins: effects of inflammatory cytokines and neointima formation in culture
MF Crook et al.
ATHEROSCLEROSIS (2000)
Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3
SJ George et al.
CIRCULATION (2000)
Acute glucose-induced downregulation of PKC-beta II accelerates cultured VSMC proliferation
M Yamamoto et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2000)
分享论文
